Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy

NCT03017885

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Zydus Hospitals and Healthcare Research Pvt. Ltd Anand, India
  • Narayana Hrudyalaya Bangalore, India
  • Manipal Hospitals Bengaluru, India
  • HCG Hospital Bengaluru, India
View Trial Details
Completed

Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC

NCT02337530

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Abbotsford Centre Abbotsford British Columbia, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)

NCT03976518

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UO Oncologia Polmonare - AOU S. Luigi Gonzaga Orbassano, Torino, Italy
  • UO di Oncologia Medica - Azienda Ospedaliero-Universitaria S. Orsola Malpighi Bologna, Italy
  • Dipartimento di Oncologia Medica - Azienda Ospedaliera S.Croce e Carle Cuneo - Ospedale Carle Cuneo, Italy
  • S.S. di Oncologia Medica toraco-polmonare - Fondazione IRCCS - Istituto Nazionale Tumori Milan, Italy
View Trial Details
Completed

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

NCT05005273

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0080 Tucson, Arizona, United States
  • Local Institution - 0051 Fountain Valley, California, United States
  • Local Institution - 0070 Fort Myers, Florida, United States
  • Local Institution - 0073 Gainesville, Florida, United States
View all 71 locations
View Trial Details
Completed

Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung Cancer

NCT04808050

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Sydney, New South Wales, Australia
  • Research Site Brisbane, Queensland, Australia
  • Research Site Perth, Western Australia, Australia
  • Research Site Alexandria, Egypt
View all 25 locations
View Trial Details

Related conditions